跳至主要内容
临床试验/NCT04945824
NCT04945824终止早期 1 期

An Open-label, Multi-center, Bilateral, Human Factors Study to Evaluate the Utilization and Safety of a Novel Intracanalicular Insertion Device in Healthy Subjects

Ocular Therapeutix, Inc.1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2021年6月1日最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
终止
入组人数
2
试验地点
1
主要终点
Ease of insertion as assessed by Post-Insertion Investigator Questionnaire

研究概览

简要总结

This is an open-label, multi-center, bilateral, human factors study designed to evaluate the utilization and safety of a novel intracanalicular insertion device in healthy subjects and to evaluate the concentration of DEXTENZA in tears. Each subject's participation is expected to last for approximately 1 month from the DEXTENZA insertion.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Are a healthy adult subject aged 18 years or older with no known significant health problems
  • Are willing to refrain from wearing contact lens for the duration of the study
  • Are willing and able to comply with clinic visits and study related procedures
  • Are willing and able to sign the informed consent form

排除标准

  • Have known significant health problems
  • Are women of reproductive potential
  • Are breastfeeding
  • Are a known steroid responder
  • Have a history of herpes simplex virus keratitis or present active bacterial, viral, or fungal keratitis in either eye
  • Have a history of complete punctal occlusion in one or both punctum
  • Currently use topical ophthalmic steroid medications
  • Are unwilling or unable to comply with the study protocol
  • Are determined by the Investigator to not be included for reasons not already specified (e.g., systemic, behavioral, or other ocular

研究组 & 干预措施

Novel Intracanalicular Insertion Device

Experimental

干预措施: Dexamethasone Ophthalmic (Drug)

Novel Intracanalicular Insertion Device

Experimental

干预措施: Dilator (Device)

结局指标

主要结局

Ease of insertion as assessed by Post-Insertion Investigator Questionnaire

时间窗: Assessed at Visit 1 (Day 1)

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验